Overview
Ritsuko Komaki is a Radiation Oncologist in Houston, Texas. Dr. Komaki is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Esophageal Cancer.
Her clinical research consists of co-authoring 233 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 108 articles in the study of Non-Small Cell Lung Cancer (NSCLC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MD Anderson
Zhongxing Liao is a Radiation Oncologist in Houston, Texas. Dr. Liao is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Esophageal Cancer, and Small Cell Lung Cancer (SCLC).
MD Anderson
Joe Chang is a Radiation Oncologist in Houston, Texas. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC).
MD Anderson
Steven Lin is a Radiation Oncologist in Houston, Texas. Dr. Lin is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Esophageal Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Endoscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Esophageal CancerDr. Komaki isElite. Learn about Esophageal Cancer.
- Lung CancerDr. Komaki isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Distinguished
- Pleuropulmonary BlastomaDr. Komaki isDistinguished. Learn about Pleuropulmonary Blastoma.
- Thymic Epithelial TumorDr. Komaki isDistinguished. Learn about Thymic Epithelial Tumor.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Komaki isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AstrocytomaDr. Komaki isExperienced. Learn about Astrocytoma.
- Bone TumorDr. Komaki isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Komaki isExperienced. Learn about Brain Tumor.
- Breast CancerDr. Komaki isExperienced. Learn about Breast Cancer.
- EGFR Positive Lung CancerDr. Komaki isExperienced. Learn about EGFR Positive Lung Cancer.
